Sun Pharmaceuticals has emerged as a key speciality player, with global speciality revenues rising from 7% in FY18 to 18% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback